Your browser doesn't support javascript.
loading
Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon, Mijung; Kim, Jae-Hoon; Rybak, Yevangelina; Luna, Alex; Choi, Chel Hun; Chung, Joon-Yong; Hewitt, Stephen M; Adem, Asha; Tubridy, Elizabeth; Lin, Juan; Libutti, Steven K.
Afiliación
  • Kwon M; Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Kim JH; Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 135-720, Korea.
  • Rybak Y; Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul 135-720, Korea.
  • Luna A; Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Choi CH; Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Chung JY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea.
  • Hewitt SM; Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Adem A; Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Tubridy E; Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Lin J; Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Libutti SK; Department of Surgery, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Oncotarget ; 7(47): 77052-77070, 2016 Nov 22.
Article en En | MEDLINE | ID: mdl-27776341
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Resistencia a Antineoplásicos / Péptidos y Proteínas de Señalización Intracelular / Beta Catenina Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Resistencia a Antineoplásicos / Péptidos y Proteínas de Señalización Intracelular / Beta Catenina Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos